- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03158870
Surgeon-Anesthesiologist Collaboration (CCAP)
May 17, 2017 updated by: Hospices Civils de Lyon
Influence of Surgeon-anesthesiologist Collaboration on Patient Outcomes After Pheochromocytoma Surgery
Collaboration between the surgeon and the anesthesiologist is key for delivering a safe pheochromocytoma surgery.
This study aims to establish the collective performance of surgeon-anesthesiologist team by quantifying the relationship between their previous collaborations and patient complications.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
1122
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Antoine DUCLOS, MD, PhD
- Phone Number: +33 04 72 11 51 66
- Email: antoine.duclos@chu-lyon.fr
Study Contact Backup
- Name: Jean-Christophe LIFANTE, MD, PhD
- Phone Number: +33 04 78 56 90 95
- Email: jean-christophe.lifante@chu-lyon.fr
Study Locations
-
-
-
Pierre-Bénite, France, 69495
- Pôle Information Médicale Evaluation Recherche des Hospices Civils de Lyon - Centre Hospitalier Lyon Sud
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients operated for pheochromocytoma
Description
Inclusion Criteria:
- All patients who underwent surgical procedure for pheochromocytoma in 8 French university hospitals from January 2000 to December 2016
Exclusion Criteria:
- Age < 18 years old
- Patients operated for incidentaloma or with paraganglioma diagnosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Pheochromocytoma
Patient who underwent surgical procedure for pheochromocytoma
|
Assessment of the influence of surgeon-anesthesiologist collaboration on surgery complications during and up to 30 days after pheochromocytoma surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of an intraoperative hemodynamic instability
Time Frame: At the time of surgery (less than 4 hours)
|
An intraoperative hemodynamic instability is defined as the occurrence of at least one intraoperative episode of systolic blood pressure ≥ 160 mmHg and at least one episode of mean blood pressure ≤ 60 mmHg
|
At the time of surgery (less than 4 hours)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 1, 2017
Primary Completion (Anticipated)
December 1, 2017
Study Completion (Anticipated)
December 1, 2017
Study Registration Dates
First Submitted
May 17, 2017
First Submitted That Met QC Criteria
May 17, 2017
First Posted (Actual)
May 18, 2017
Study Record Updates
Last Update Posted (Actual)
May 18, 2017
Last Update Submitted That Met QC Criteria
May 17, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL17_0030
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pheochromocytoma
-
National Cancer Institute (NCI)RecruitingMetastatic Adrenal Gland Pheochromocytoma | Metastatic Paraganglioma | Unresectable Adrenal Gland Pheochromocytoma | Unresectable Paraganglioma | Advanced Adrenal Gland Pheochromocytoma | Advanced Paraganglioma | Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 | Stage...United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Adrenal Gland Pheochromocytoma | Locally Advanced Paraganglioma | Metastatic Paraganglioma | Unresectable Adrenal Gland Pheochromocytoma | Unresectable Paraganglioma | Regional Adrenal Gland PheochromocytomaUnited States
-
Peking Union Medical College HospitalRecruitingPheochromocytoma, Metastatic | Paraganglioma, Malignant | Pheochromocytoma MalignantChina
-
Peking Union Medical College HospitalRecruitingUltrasonography | Pheochromocytoma, Metastatic | Paraganglioma, Malignant | Pheochromocytoma MalignantChina
-
Abramson Cancer Center of the University of PennsylvaniaCompletedUnresectable Paraganglioma | Recurrent Pheochromocytoma | Advanced Metastatic Paraganglioma | Advanced Metastatic Pheochromocytoma | Recurrent Paraganglioma | Unresectable PheochromocytomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMetastatic Adrenal Gland Pheochromocytoma | Malignant Adrenal Gland Pheochromocytoma | Malignant ParagangliomaUnited States
-
Peking Union Medical College HospitalCompletedPheochromocytoma, Metastatic | Paraganglioma, Malignant | Pheochromocytoma MalignantChina
-
Peking Union Medical College HospitalRecruitingParaganglioma, Extra-Adrenal | Malignant Adrenal Gland Pheochromocytoma | Malignant Paraganglioma | Pheochromocytoma, Metastatic | Paraganglioma, MalignantChina
-
National Cancer Institute (NCI)TerminatedParaganglioma | Metastatic Adrenal Gland Pheochromocytoma | Recurrent Adrenal Gland Pheochromocytoma | Extra-Adrenal ParagangliomaUnited States, Singapore, Hong Kong
-
Kunwu Yan,MMCompletedHemodynamic | Adrenal Pheochromocytoma
Clinical Trials on Surgery complications
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownColorectal Cancer | Perioperative/Postoperative ComplicationsNetherlands
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedColorectal Cancer | Anal Cancer | Perioperative/Postoperative ComplicationsUnited States
-
Maastricht University Medical CenterCompletedPost-Infarction Ventricular Septal Defect | Post-Infarction Heart Rupture | Post-Infarction Mitral Papillary Muscle RuptureNetherlands
-
Southwest Oncology GroupNational Cancer Institute (NCI); Agency for Healthcare Research and Quality...CompletedUnspecified Adult Solid Tumor, Protocol Specific | Constipation, Impaction, and Bowel ObstructionUnited States, Canada, Colombia, Peru, Mexico
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Precancerous Condition | Perioperative/Postoperative ComplicationsUnited States
-
Nantes University HospitalCompletedBrain Tumor | Post-operative Complications | Neuro-surgery | Neuro-ICU StayFrance
-
Mayo ClinicNational Cancer Institute (NCI)CompletedTobacco Use Disorder | Lung Cancer | Perioperative/Postoperative Complications | Pulmonary ComplicationsUnited States
-
Azienda Ospedaliera di PadovaUnknownColorectal Cancer | Perioperative/Postoperative Complications | Gastrointestinal ComplicationsItaly
-
Roswell Park Cancer InstituteWithdrawnPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditions